{
    "2019-03-20": [
        [
            {
                "time": "",
                "original_text": "年营收400亿！增速秒杀恒瑞、石药！这货业绩如此彪悍，什么东西？",
                "features": {
                    "keywords": [
                        "营收",
                        "增速",
                        "恒瑞",
                        "石药",
                        "业绩"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "科创板生物医药公司系列研究之复旦张江:自主产权核心技术管线丰富,拳头品种持续放量",
                "features": {
                    "keywords": [
                        "科创板",
                        "生物医药",
                        "复旦张江",
                        "核心技术",
                        "管线",
                        "拳头品种"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-03-20",
                "original_text": "收盘突破年线个股一览",
                "features": {
                    "keywords": [
                        "收盘",
                        "突破",
                        "年线"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药：持有复旦张江22.77%股份",
                "features": {
                    "keywords": [
                        "上海医药",
                        "复旦张江",
                        "股份"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药周观点:业绩浪、长期资金持续流入,医药蓝筹白马股价历史新高再新高",
                "features": {
                    "keywords": [
                        "医药",
                        "业绩浪",
                        "长期资金",
                        "蓝筹",
                        "白马股",
                        "股价新高"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}